机译:在增强由MF59辅助大流行前疫苗引发的长寿命人记忆B细胞后,广泛交叉反应的抗体快速上升
Translational Medicine, Novartis Vaccines, Siena, Italy 53100;
Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30333;
Health Protection Agency, Colindale, London NW9 5HT, United Kingdom;
Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30333;
Regulatory Affairs and Statistics, Novartis Vaccines, 35041 Marburg, Germany;
Translational Medicine, Novartis Vaccines, Siena, Italy 53100;
Translational Medicine, Novartis Vaccines, Siena, Italy 53100;
Translational Medicine, Novartis Vaccines, Siena, Italy 53100;
University of Siena, 53100 Siena, Italy;
Department of Inflammation, Infection and Immunity, University of Leicester, Leicester LE1 9HN, United Kingdom;
Translational Medicine, Novartis Vaccines, Siena, Italy 53100;
Regulatory Affairs and Statistics, Novartis Vaccines, 35041 Marburg, Germany;
Regulatory Affairs and Statistics, Novartis Vaccines, 35041 Marburg, Germany;
University of Siena, 53100 Siena, Italy;
Health Protection Agency, Colindale, London NW9 5HT, United Kingdom;
Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30333;
Department of Inflammation, Infection and Immunity, University of Leicester, Leicester LE1 9HN, United Kingdom;
Department of Inflammation, Infection and Immunity, University of Leicester, Leicester LE1 9HN, United Kingdom;
机译:对新型H5NX流感病毒的交叉反应性抗体应对在同源和异源性素 - 增压疫苗接种中,在人类中具有预备储存的A(H5N1)疫苗
机译:异源MF59佐剂的H5N1大流行前流感增强疫苗在成人和老年人中诱导强大,交叉反应的免疫反应。
机译:异源MF59佐剂的H5N1大流行前流感增强疫苗在成人和老年人中诱导强大,交叉反应的免疫反应。
机译:响应辅助流感疫苗的人体免疫细胞的定量蛋白质组学及其分析
机译:使用腺病毒和腺伴随病毒载体的初免-加强疫苗策略诱导针对I型人免疫缺陷病毒的CD8 + T细胞应答
机译:在增强由MF59辅助大流行前疫苗引发的长寿命人记忆B细胞后广泛交叉反应的抗体快速上升
机译:在增强由MF59辅助大流行前疫苗引发的长寿命人记忆B细胞后,广泛交叉反应的抗体快速上升
机译:汉坦/安第斯山脉病毒DNa疫苗在非人类灵长类动物中引发广泛的交叉反应中和抗体反应